Combination therapy for COVID-19 in hemodialysis patients: Pharmacological treatments and renal replacement therapy based on the severity
- PMID: 34533292
- PMCID: PMC8652437
- DOI: 10.1111/1744-9987.13737
Combination therapy for COVID-19 in hemodialysis patients: Pharmacological treatments and renal replacement therapy based on the severity
Conflict of interest statement
The authors declare no potential conflict of interest.
Comment on
-
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States.Am J Kidney Dis. 2021 Feb;77(2):190-203.e1. doi: 10.1053/j.ajkd.2020.09.003. Epub 2020 Sep 19. Am J Kidney Dis. 2021. PMID: 32961244 Free PMC article.
References
-
- Hirasawa H, Oda S, Nakamura M, Watanabe E, Shiga H, Matsuda K. Continuous hemodiafiltration with a cytokine‐adsorbing hemofilter for sepsis. Blood Purif. 2012;34(2):164–70. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical